Mark Fletcher Net Worth & Insider Trades
Mark Fletcher - EVP General Counsel &Secretary, Generex Biotechnology Corp
What is Mark Fletcher's Net Worth?
The current estimated net worth of Generex Biotechnology Corp's EVP General Counsel &Secretary, Mark Fletcher, is estimated to be about $263.02K . Mark Fletcher owns about 286,077 units of Generex Biotechnology Corp common stock. In the last 13 years at Generex Biotechnology Corp, Mark Fletcher has sold an estimated value of $262.88K worth.
What is Mark Fletcher's Past Insider Trading?
Mark Fletcher's largest purchase order was 250,000 units , worth over $222.5K on April 21, 2008. Mark Fletcher's largest sale order was 228,342 units , worth over $262.88K on April 21, 2008. In total, Mark Fletcher has made about 18 transactions over 13 years of their time at Generex Biotechnology Corp. Mark Fletcher usually trades in April, with the busiest year in 2013. The most recent transaction was a purchase order of 20,000 units , worth over $4.78K on April 7, 2011.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mark Fletcher
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Mark Fletcher's' Mailing Address?
- Mailing address is 4145 North Service Road, Suite 200 Burlington A6 L7L6A3 Ontario, Canada
What are Generex Biotechnology Corp's Past Insider Trades?
Generex Biotechnology Corp's most recent insider trade came on December 14, 2018 by Harold Gray Haines who bought 1,500 units worth $3.17K . In the last 15 years, insiders at Generex Biotechnology Corp have sold an estimated value of $443.18K and bought an estimated value of $736.47K worth of shares. Insider trading is most common in November and June, with the busiest year in 2013. The most active traders at the company are Mark Fletcher, EVP General Counsel &Secretary, Rose C Perri, Director, and Brian McGee, Director .
GENEREX BIOTECHNOLOGY CORP Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |